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Abstract
Genome-wide association studies (GWASs) identify single nucleotide polymorphisms (SNPs) that are enriched in individuals
suffering from a given disease. Most disease-associated SNPs fall into non-coding regions, so that it is not straightforward to
infer phenotype or function; moreover, many SNPs are in tight genetic linkage, so that a SNP identified as associated with
a particular disease may not itself be causal, but rather signify the presence of a linked SNP that is functionally relevant to
disease pathogenesis. Here, we present an analysis method that takes advantage of the recent rapid accumulation of
epigenomics data to address these problems for some SNPs. Using asthma as a prototypic example; we show that non-
coding disease-associated SNPs are enriched in genomic regions that function as regulators of transcription, such as
enhancers and promoters. Identifying enhancers based on the presence of the histone modification marks such as
H3K4me1 in different cell types, we show that the location of enhancers is highly cell-type specific. We use these findings to
predict which SNPs are likely to be directly contributing to disease based on their presence in regulatory regions, and in
which cell types their effect is expected to be detectable. Moreover, we can also predict which cell types contribute to
a disease based on overlap of the disease-associated SNPs with the locations of enhancers present in a given cell type.
Finally, we suggest that it will be possible to re-analyze GWAS studies with much higher power by limiting the SNPs
considered to those in coding or regulatory regions of cell types relevant to a given disease.
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Introduction
Asthma is a chronic inflammatory disease, characterized by
reversible airway obstruction and increased bronchial hyperre-
sponsiveness. This complex disorder is influenced by the
interdependencies between various factors - genetic and environ-
mental being the most important ones. The estimate that 35–80%
of the variation in the risk of asthma can be attributed to genetic
variation has spurred a number of genome-wide association
studies (GWASs) of asthma [1–17], making it one of the best
studied diseases to date. Most of these studies involved genotyping
asthmatic vs. non-asthmatic donors using single nucleotide poly-
morphism (SNP) arrays that can detect the presence or absence of
up to a million SNPs [10]. Using information from studies such as
The 1000 genomes [18] and Hap Map projects [19], the presence
of additional SNPs not present on the genotyping arrays can be
extrapolated by imputation [20,21]. GWASs have led to the
discovery of a large set of SNPs that are significantly more frequent
in patients with asthma compared to individuals without asthma or
healthy controls. However, identifying a functional link between
the presence of an asthma-risk SNP and development of disease
has not been straightforward [22], primarily because the majority
of identified SNPs are located in non-coding regions so that there
is no obvious expected phenotype or function, but also because of
the tight genetic linkage of SNPs in a haploblock, only few of
which will have a functional effect.
Recently, there has been a vast acceleration in the identification
of non-coding genomic elements that regulate gene transcription
[23,24]. This has been enabled by the advent of genome-wide
chromatin analysis, such as profiling of the histone mark
H3K4me1 (histone 3 lysine 4, monomethylation). This mark is
found on histones associated with genomic regions accessible to
regulatory DNA-binding proteins (transcription factors), which
thereby function as enhancers of transcription. Enhancers could
also be marked by other protein modifications, e.g. H3K4me2
(histone 3 lysine 4, dimethylation), H3K27ac (histone 3 lysine 27,
acetylation), as well as histone variant H2A.Z [25–27]. In this
study, we focused on the H3K4me1 and H3K27ac marks as more
data were publicly available for these markers.
Notably, the location of enhancers is highly cell-type specific
[28], supporting the notion that different cell types maintain their
specialized functions by selectively activating different regulatory
regions of the genome [29]. Moreover, several recent studies have
shown that disease-associated SNPs are enriched in enhancers
[29–32].
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Based on these considerations, we tested the hypothesis that
SNPs associated with a specific disease are more frequently found
in enhancers specific to cells that are relevant for the disease. Using
asthma as an example, we document a significant enrichment of
asthma-associated SNPs in genomic regions marked by H3K4me1
in CD4+ T cells, which are known to contribute to asthma
pathogenesis. In contrast, cells from brain, breast and skeletal
muscle tissues unrelated to asthma, are depleted of asthma-
associated SNPs in their enhancer regions. Thus, the methodology
we report here can be utilized to make an unbiased prediction of
which cell types contribute to disease pathogenesis, and which
disease-associated SNPs are likely to be functionally important.
Results
The Majority of Asthma-associated SNPs is Located in
Non-coding Regions
We retrieved all known asthma-associated SNPs from the
GWAS integrator database [33], resulting in 131 SNPs (Table S1
in File S1). For all these directly disease-associated SNPs, we also
retrieved SNPs in tight genetic linkage (n = 2510, r2 = 0.8) based
on the most recent release of HaploReg [30] (Table S2 in File S1).
As a background control set, we assembled non-asthma-associated
SNPs from DbSNP135Common dataset of the UCSC Browser
[34,35]. The distribution of the three sets of SNPs in coding
regions (cds), 59-untranslated regions (59-UTRs), 39-UTRs, in-
trons, and intergenic regions is shown in Figure 1. As expected,
asthma-associated SNPs were highly enriched in coding sequences
compared to the background set of SNPs, and a significant but
lower enrichment was found for 39- and 59-UTRs. However, the
largest proportion of asthma-associated SNPs was found in introns
and intergenic regions, i.e. non-coding sequences known to
contain enhancers.
Non-coding SNPs are Significantly Enriched in Enhancers
In an elegant study by the Kellis group [36], genomic regions in
CD4+ T cells were comprehensively classified into different
chromatin states using a Hidden Markov Model. We used these
classifications to examine if any chromatin states were enriched for
asthma-associated SNPs. As shown in Table S3 in File S1, we
found enrichment of disease-associated SNPs in promoter states
(state 1–9, and 11), and in some states associated with transcription
(states 12, 14, 21 and 24) - result already anticipated from Figure 1.
In addition, we have detected an enrichment of asthma SNPs in
many active intergenic states (State 29, 30, 34–36).
In contrast, regions with heterochromatin state and repetitive
elements (states 40–42, and 48) showed high depletion for disease-
associated SNPs, as did some states associated with transcription
(states 15, 17–19, 23 and 28).
Notably, we also found significant enrichment in States 9, and
34, which are associated with promoter and enhancer regions,
suggesting that SNPs present in non-coding regions (enhancers
and promoters) contribute to disease pathogenesis by perturbing
the transcriptional regulation of an associated gene.
The Location of Active Enhancers is Primarily a Function
of Cell Type
Enhancers have previously been reported to be tissue and cell-
type specific [37,38]. To determine if the SNP enrichment in
enhancers that we found for CD4+ T cells (which are known
contributors to asthma) was a cell-type specific effect, we
compared the available data on the distribution of the
H3K4me1 modification for human CD4+ T cells and several
other human tissues/organs using published studies. We obtained
all available H3K4me1 Chromain ImmunoPrecipitation (ChIP)-
Seq data from the epigenome atlas [39,40] limiting our analysis to
data for which both IP and control input samples were available. A
total of 37 samples from 19 distinct cell types and 8 tissues were
retrieved, and putative enhancers in each dataset were identified
by H3K4me1 peak calling (Materials and Methods). As an
example of cell type-specific distribution of H3K4me1, Figure 2
shows the extended Th2 cytokine locus. The well-known locus
control region LCR-O and the hypersensitivity site (HS) V, which
both function as enhancers in CD4+ T cells, are marked in red
boxes [41]. Importantly, there are H3K4me1 peaks at these
regions in six CD4+ T cell types (Figure 2), but no peaks were
found in the kidney, liver or brain cells. This result demonstrates
that our method for calling H3K4me1 peaks accurately identifies
known enhancers.
Next, we compared the enhancers identified in different
datasets by calculating pair-wise Matthews correlation coeffi-
cients (MCC), which quantify the overlap of enhancers on a per
nucleotide basis (see Materials and Methods). Figure 3 depicts
a MCC heatmap for all studied datasets, which fell into 10
distinct clusters using a cutoff for pairwise MCC values above
0.55. Two samples formed isolated clusters, and were consid-
ered outliers (sample 7, Adipose Nuclei, and sample 28, Brain
Figure 1. Distribution of the SNPs in coding, 59-UTR, 39-UTR, introns and intergenic regions. Three sets of SNPs are shown. SNPs
identified as being significantly associated with asthma according to the GWAS Integrator database [33] are shown on the left. The middle shows the
same set of SNPs extended by those that are in tight genetic linkage (r2 = 0.8) according to HaploReg [30]. On the right, the distribution of common
SNPs that are not associated with asthma is shown. The distribution of SNPs into coding, 59-UTR, 39-UTR, introns, and intergenic regions was done
using RefSeq datasets from the UCSC Genome Browser [34,35].
doi:10.1371/journal.pone.0054359.g001
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Germinal). Apart from these exceptions, all datasets from the
same cell types but different laboratories or different donors fell
into the same cluster. For example, all nine datasets of CD4+ T
cell-types were in one cluster, as were all dataset from different
brain regions. This demonstrated that the genomic location of
enhancers marked by H3K4me1 was primarily determined by
cell type, and donor-to-donor variability was not a significant
factor.
Non-coding SNPs Associated with Asthma are Enriched
in CD4+ T Cell Specific Enhancers
To determine if there was differential enrichment of asthma-
associated SNPs in the enhancers of different cell types, we
merged the enhancers identified in each of the eight cell/tissue
type specific clusters displayed in Figure 3 to obtain a single set
of enhancers per cell/tissue type. In each of these eight sets, we
determined how many asthma-associated SNPs were found in
enhancers, and calculated enrichment over the background SNP
distribution. As shown in Table 1, we saw the biggest
enrichment (2.11) of asthma-associated SNPs in CD4+ T cells,
and we also detected some enrichment of asthma SNPs in liver,
adipose nuclei and adipose stem cells. However, for cells from
skeletal muscle, breast myoepithelial or brain, asthma-associated
SNPs were depleted in enhancer regions. This depletion makes
intuitive sense, as these cell types are thought not to be major
contributors to asthma. As a control, we also calculated the
enrichment of asthma SNPs using different background distri-
bution, namely the SNP panels present on the most commonly
used typing arrays (Affymetrix 6.0, Illumina 550, Illumina 650
and Illumina 1MDuo). As was expected, we consistently found
the highest enrichment of asthma SNPs in enhancers of CD4+
T cells, and also determined enrichment in four tissues
considered significant in our original analysis (CD4+ T, liver,
adipose nuclei, and adipose derived mesenchymal stem cells),
while finding lesser enrichment in the remaining tissues (kidney,
brain, skeletal muscle and breast myoepitethelial cells, Table S4
in File S1).
Next, we performed a similar analysis using a second enhancer
marker, H3K27ac (Table 2). H3K27ac is known to distinguish
active enhancers from inactive/poised enhancer elements contain-
ing H3K4me1 alone [38]. Due to the more selective nature of this
marker, we expected to find a higher enrichment of disease
associated SNPs. However, we found that asthma- SNPs
enrichment in CD4+ T cell H3K27ac peaks was essentially the
same as in CD4+ T cell H3K4me1 peaks. (2.12 and 2.11
respectively). Additionally, almost all asthma SNPs that belong to
CD4+ T cell H3K27ac peaks were also located in CD4+ T cell
Figure 2. Asthma-associated SNPs and H3K4me1-enriched regions (enhancers) in the human Th2 cytokine locus of different cells
and tissue types. From top to bottom, using the UCSC genome browser, are displayed: the conserved DNAse hypersensitivity regions identified in
mouse T cells (HS regions), the gene track (genes), all the SNPs not associated with asthma, the SNPs associated with asthma, the species
conservation track, the H3K4me1 ChIP-seq track (green) for the different cell and tissue types (named on the left) underlined by corresponding peak
calling track (black boxes). For the blood CD4+ T cells, peak calling tracks from seven samples/cell-types are displayed. The red boxes show H3K4me1
peaks that are present only in CD4+ T cells (LCRO and HSV).
doi:10.1371/journal.pone.0054359.g002
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H3K4me1 peaks (230 out of 254). Notably, by focusing on
H3K27ac mark we not only fail to obtain higher enrichment of
disease associated SNPs, but we also lose about 40% of possible
functionally important SNPs. Overall, the analysis if H3K27ac
marks supports the findings we had for H3K4me1, and suggests
that an analysis of a single marker H3K4me1 might be sufficient to
obtain all information.
We asked whether the enrichment for asthma-associated
SNPs could be increased by excluding ubiquitous enhancers
found in many cell types/tissues. Figure 4 shows for each tissue
the number of asthma-associated SNPs located in cell type-
specific enhancers (black boxes show asthma-associated SNPs in
which an enhancer is present in that cell type whereas open
boxes show SNPs with no enhancer). Of the 884 SNPs that fell
into enhancers in one or more of the eight tissues, the by far
largest number (443) was found exclusively in a single tissue. A
much smaller number (39) was found in all eight tissues.
Figure 5 shows that the enrichment of asthma-associated SNPs
compared to background SNPs in enhancers of CD4+ T cells
increased moderately when enhancers found in many other cell
types were excluded.
The highest enrichment was determined by considering either
the SNPs unique to CD4+ T cells, or SNPs found in up to two
other cell types. By contrast, enhancers in skeletal muscle cells
were clearly depleted of asthma-associated SNPs, and such
depletion became increasingly pronounced when excluding
enhancers also found in other cell types. A similar, but less
pronounced, trend was found for cells from breast and brain
Figure 3. The location of enhancers is cell-type specific. The plot depicts pairwise comparisons of the location of enhancers in different
datasets using Matthew Correlation Coefficients (MCC). Black indicates a high correlation between enhancers in two cell types. The 37 studied
datasets form distinct clusters that correspond to different cell- or tissue types.
doi:10.1371/journal.pone.0054359.g003
Table 1. Asthma SNPs enrichment in enhancers of different tissues.
Cell type
asthma SNPs (out of
2,510)
non-asthma SNPs (out of 11.3
million) enrichment
p-value for chi-square
test
CD4+ T Cells 430 921,179 2.11 ,0.0001
Liver 282 970,466 1.31 ,0.0001
Adipose Nuclei 376 1,402,437 1.21 ,0.0001
Adipose Stem Cells 378 1,478,423 1.15 0.0028
Kidney 177 755,135 1.06 0.4386
Breast Myoepithelial Cells 182 978,214 0.84 0.0135
Skeletal Muscle 192 1,047,059 0.83 0.0058
Brain 202 1,190,305 0.77 ,0.0001
doi:10.1371/journal.pone.0054359.t001
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tissues (Table S5 in File S1), whose enhancers are depleted of
asthma-associated SNPs and become more depleted when
eliminating enhancers shared with other cell types. For the
remaining cell types (liver and adipose tissues), which showed an
enrichment of asthma SNPs in their enhancers, the enrichment
increased further when considering subsets of enhancers unique
to these cells.
To examine the putative functional mechanism of asthma SNPs
in enhancers, we were interested if might modulate in Transcrip-
tion Factor Binding Sites (TFBSs). Figure 6 shows the distribution
of asthma-associated SNPs in TFBSs determined by ChIP-seq
experiments. Strikingly, asthma-associated SNPs located in en-
hancers overlap with TFBSs four times more often than those not
located in enhancers. This finding supports our hypothesis that
non-coding disease-associated SNPs in enhancers are more likely
to be functional, and may do so by disrupting binding of
transcription factors.
In summary, our analysis demonstrates that focusing on
enhancers present in a few cell types further enriched asthma-
associated SNPs compared to background SNPs. Since by far the
greatest enrichment was observed at enhancers of CD4+ T cells
which are known to contribute to asthma, our approach is capable
of simultaneously prioritizing those SNPs that are more likely to
contribute to a given disease, and identifying the cell types
involved.
Prediction of Putative Functionally Important SNPs
Based on the reasoning that functional disease-associated non-
coding SNPs are likely to dysregulate gene expression by
disrupting function of key cis-regulatory elements (enhancers)
present in cell types that drive disease pathogenesis such as CD4+
T cells, we predict that SNPs present in such cell-type-specific
enhancer regions (marked as red dotted line, Figure 2) are more
likely to be biologically important than SNPs present in common
enhancer regions or in non-enhancer regions. Thus we speculate
that the non-coding SNPs (red boxes) present in the LCR-O and
HS-V enhancers of the Th2 cytokine locus (Figure 2), the 59 end of
the IL18R1 gene in the IL1RL1/IL18R1 locus (Figure 7), and
IKZF3 locus (Figure S1 in File S1) are likely to modulate the
function of the corresponding cell-type-specific enhancers in
CD4+ T cells. Therefore, this enhancer and the risk-SNPs it
bears are likely to the most relevant to asthma pathogenesis and
experimental studies that seek to validate function of disease-
associated SNPs should prioritize these.
Discussion
Unraveling how common genetic variations contribute to
disease development is complicated, as the effect of a genetic
variation may be limited to a certain developmental stage and/or
cell type, and may be dependent on the presence of additional
Table 2. Asthma SNPs enrichment in H3K27Ac of different tissues.
Cell type
asthma SNPs
(out of 2,510)
non-asthma SNPs (out of 11.3
million) enrichment p-value for chi-square test
CD4+ T Cells 254 539,868 2.12 ,0.0001
Adipose Nuclei (1 sample) 155 478,155 1.46 ,0.0001
Skeletal Muscle (1 sample) 128 499,663 1.16 0.0931
Brain (1 sample) 69 519,313 0.6 ,0.0001
doi:10.1371/journal.pone.0054359.t002
Figure 4. Distribution of enhancers in asthma-associated SNPs for different cell types. For each SNP and cell type, a black bar indicates
that an enhancer is overlapping the SNP in that cell type. Cell types are ordered by their enrichment for asthma-associated SNPs in enhancers from
breast tissue with low enrichment at the top to CD4+ T cells with high enrichment at the bottom. SNPs are ordered by how commonly they overlap
with enhancers in different cell types from those with enhancers present in all 8 cell types on the left to with enhancers in just 1 cell type on the right.
Asthma-associated SNPs with no enhancer in any cell type are left out from the graph.
doi:10.1371/journal.pone.0054359.g004
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environmental factors. Our analysis of asthma-associated SNPs
demonstrates how this problem can be tackled by the use of
epigenetic information, which identifies which genomic regions
are active in different cell types.
Previously, Pham and colleagues explored the association
between potential enhancers and disease-associated variants
extracted from a comprehensive GWAS catalogue [42]. Their
primary focus was on promoter-distal regions marked by
H3K4me1 and/or H3K27ac. Specifically, the authors have
validated a novel macrophage-specific enhancer signature encom-
passing ETS, CEBP, bZIP, EGR, E-Box and NFkB motifs by
ChIP-sequencing, which confirmed their associations with epige-
netic changes related to differentiation. Another, recent study by
Maurano et al. [43] examined the distribution of 5,654 noncoding
significant associations (5,134 SNPs) for 207 diseases and 447
quantitative traits. By combining with the deep genome-scale
maps of regulatory DNA marked by DNase I hypersensitive sites
(DHSs), their study has revealed a collective 40% enrichment of
GWAS SNPs in DHSs. For externally replicated non-coding
SNPs, 69.8% reside within a DHS. Of GWAS SNPs in DHSs,
93.2% (2,874) overlap a transcription factor recognition site.
Common variants associated with specific diseases or trait classes
were systematically enriched in the recognition sequences of
transcription factors governing physiological processes relevant to
the same classes. Our studies are in agreement with these findings,
and suggest that the combined analysis of GWAS and epigenetic
information predicts which SNPs are more likely to be functionally
contributing to disease and in which cell types these effects will be
Figure 5. Distribution of enhancers in asthma-associated SNPs for different cell types. Plotted is the enrichment of asthma-associated
SNPs compared to background SNPs in genomic regions in which there are CD4+ T enhancers, and anywhere from –0 to 7 additional cell types that
also have a peak in that region.
doi:10.1371/journal.pone.0054359.g005
Figure 6. Distribution of the asthma-associated SNPs in TFBSs. Two sets of asthma-associated SNPs are shown. Asthma-associated SNPs that
belong to any of H3K4me1 peaks called in this study are shown on the left. On the right, the distribution of asthma-associated SNPs that are located
in any of H3K4me1 peaks. The distribution of SNPs into overlapping and non-overlapping TFBSs was done using TFBSs by ChIP-seq dataset from the
ENCODE (Release 2) [55]. The TFBSs ChIP-seq data were obtained from UCSC Genome Browser [34,35].
doi:10.1371/journal.pone.0054359.g006
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noticeable. With the rapidly increasing amount of epigenetic data
for different human tissues in different developmental stages, such
analysis will become increasingly powerful.
Significant progress has been made with respect to the
ENCyclopedia Of DNA Elements (ENCODE) project after our
initial results were submitted for publication [44–45]. Multiple
types of ENCODE data can now be linked with disease-associated
SNPs, that could help pinpointing regulatory regions with
significant enrichment for functional SNPs [46]. Researchers have
employed ENCODE epigenetic data as a guide to unveil
regulatory regions in which genetic variants could affect a given
complex trait. For instance, Farrell et al. [47] applied ENCODE
data to uncover the function of a DNA fragment encompassing a 3-
bp deletion polymorphism, which is shown to have enhancer-like
activity. The 3-bp deletion polymorphism could possibly represent
the most significant functional motif accounting for HBS1L-MYB
intergenic polymorphism associated with the trait of interest, fetal
hemoglobin.
Our present analysis is meant more as a proof of concept than
an optimized, definitive study; there are multiple ways in which it
can be significantly improved. First, the amount of published
asthma-associated SNPs is continuously increasing, with a gain of
65% from January to October 2012, and additional SNPs will
continue to be discovered. Moreover, rather than relying on SNPs
that reach statistical significance in whole genome studies, our
approach would be even more powerful when GWAS data is re-
analyzed from scratch, limiting the SNPs considered to those in
active genomic regions of the cells of interest.
Second, the peak-calling algorithm used (MACS) is not optimal
for identifying histone modifications, but was designed for
identifying much better-defined transcription factor binding sites.
Preliminary analysis showed that we obtained a higher enrichment
with other algorithms, such as SICER [48] and ZINBA [49].
Moreover, rather than calling peaks, it may be preferable to
identify enhancers based on the profiles of H3K4me1 enrichment
together with other chromatin marks as implemented in
ChromaSig [50]. The more sophisticated analysis of active
genomic regions by the Kellis group, which combined multiple
chromatin markers in CD4+ T cells, gave a higher enrichment of
disease associated SNPs than our approach of relying solely on
H3K4me1 peaks to identify enhancers. We assume that this is
both because other cis-regulatory elements such as suppressors or
isolators may well have similar importance to enhancers, and
because even for enhancers, H3K4me1 in combination with other
markers may provide a more accurate identification. We expect
classifications such as those by the Kellis group to become
available for multiple cell types in the near future. Also, the
chromatin state classifications could be further tailored to our type
of analysis by focusing on those states that show the highest
correlation with disease-associated SNPs, and identifying the
optimal set of chromatin marks that identifies these regions.
Finally, we want to reiterate that asthma-associated SNPs are
significantly enriched not only in enhancers and promoters, but
also in coding and untranslated regions. The transcription of these
regions could further depend on both genetic and epigenetic
factors.
Figure 7. Asthma-associated SNPs and H3K4me1 (enhancer) enriched regions in the human IL-33R locus of different cell/tissue
types. From top to bottom, using the UCSC genome browser, are displayed: the gene track (genes), all the SNPs not associated with asthma, the
SNPs associated with asthma (red are GWAS-identified SNPs, blue are SNPs in linkage disequilibrium), H3K4me1 ChIP-seq track (green) for different
cell/tissue types (named on the left) underlined by the corresponding peak-calling track (black boxes). For the blood CD4+ T cells, peak calling tracks
from seven samples/cell-types are displayed. The red box shows an H3K4me1 peak that is present only in CD4+ T cells.
doi:10.1371/journal.pone.0054359.g007
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In conclusion, we have demonstrated a novel approach to
GWAS data analysis that integrates epigenomic information to
identify SNPs and cell types contributing to disease. We expect our
approach to be broadly applicable, and to further enhance the
value of the accumulating information from GWAS of disease.
Future work needs to experimentally confirm the functional role of
the identified SNPs.
Materials and Methods
SNP Datasets
To create a collection of asthma related SNPs, we had all
asthma-associated variants (SNPs) downloaded from GWAS
Integrator [33] in October 2012. To ensure the completeness of
this collection, we then calculated the linked (i.e., in linkage
disequilibrium) SNPs for each asthma-associated SNP using
HaploReg tool with default parameters [30]. The total number
of asthma-associated SNPs in the combined set was 2,510. As
a control dataset, we used a common SNPs 135 (uniquely mapped
variants that appear in at least 1% of the population) dataset, and
subtracted our asthma SNPs collection. Common SNPs 135 were
obtained from UCSC Genome Browser [34]. A total number of
non-asthma SNPs was determined as 11,327,391. For calculating
asthma SNPs enrichment per GWA SNP panel, the SNPs arrays
for Affymetrix 6.0, Illumina 550, Illumina 650 and Illumina
1MDuo were downloaded from UCSC Genome Browser [34].
SNP Enrichment Calculation
To estimate distribution of asthma SNPs in different chromatin
states we used chromatin state prediction for CD4+ T-cells by
Ernst and Kellis [36]. The predictions were done for hg18 genome
assembly. To convert coordinates of our asthma and non-asthma
SNPs from hg19 to hg18 assembly we used the lift genome
annotations tools from the UCSC genome browser [http://
genome.ucsc.edu/cgi-bin/hgLiftOver]. Some non-asthma SNPs
where un-mappable by this tool, and discarded from that
calculation. For a given chromatin state, we determined the
fraction of asthma-associated SNPs located in the corresponding
genomic region, and compared it to the fraction of background
SNPs to calculate enrichments. Significance was assessed using the
chi-square test.
Identification of H3K4me1 and H3K27Ac Peaks
(enhancers)
ChIP-seq H3K4me1 data together with the input data for 37
datasets were obtained from Human Epigenome Atlas, release 5.
[http://www.genboree.org/epigenomeatlas/
edaccGridViewerPublic.rhtml].
The samples analyzed came from the following cell types. CD4+
T cells: three samples of CD4+ memory T cells, two samples of
CD4+ naive T cells, one sample of CD4+ CD25- IL17- T cells,
CD4+ CD25- T cells, CD4+ CD25- IL17+ Th17 cells, CD4+
CD25+ CD127- Treg cells; brain: brain germinal cells, brain mid
frontal and inferior temporal lobe, two samples of brain
hippocampus middle, two samples of brain anterior caudate, two
samples of brain substantia nigra and brain cingulate gyrus; three
samples of adipose derived mesenchymal (ADM) stem cells; three
samples of liver cells; two samples of kidney cells; five samples of
adipose nuclei; two samples of breast myoepithelial cells and three
samples of skeletal muscle cells. Total number of all analyzed
samples is equal to 37; the number of analyzed cell types is equal
to 19 because for some cell types data for more than one donor
was available. These 19 cell types belonged to eight different
tissues.
For each sample we calculated H3K4me1 enriched regions by
enrichment of treatment reads under a local background model
estimated from control reads by employing the statistical software
MACS (v.1.4.1, default parameter settings) [51]. Enriched regions
with a p-value #1e-5 were defined as enhancers.
All available ChIP-seq H3K27ac data for the samples that
contained H3K4me1 datasets were obtained from Human
Epigenome Atlas, release 5. Thus, we have analyzed H3K27ac
marks for the same CD4+ T cells (9 samples), one sample of brain
anterior caudate, one sample of adipose nuclei and one sample of
skeletal muscle cells. The twelve cell types mentioned above
belong to four different tissues and for each sample we have
calculated H3K27ac peaks using exactly the same parameters as
we used for H3K4me1 peak calling.
Comparing H3K4me1 Enhancers between Datasets
In order to compare the enhancers in different datasets we
calculated pair-wise Matthews correlation coefficients (MCC),
which quantify the overlap of enhancers on a per nucleotide basis.
For each pair of samples (datasets) the MCC was calculated using
the following formula:
MCC~
TP|TN{FP|FN
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TPzFPð Þ| TPzFNð Þ| TNzFPð Þ| TNzFNð Þp
where true positive (TP) was a number of nucleotides present in
common enhancers, false positive (FP) and false negative (FN)
number of nucleotides in enhancers present in one dataset but not
in the other and vice versa, and, finally true negative (TN) was the
number of nucleotides in the genome that were not called as
enhancers in either dataset. To calculate overlapping and
intersecting genome coordinates, we utilized the BEDTools
utilities package [52]. The MCC-heatmap was generated by
Cluster 3.0 [53] and visualized by TreeView [54].
Transcription Factor Binding Sites Dataset
To calculate distribution of asthma SNPs within and without
Transcription Factor Binding Sites (TFBSs) we have used TFBSs
by ChIP-seq data from the ENCODE (Release 2) [55]. The
TFBSs ChIP-seq data were obtained from UCSC Genome
Browser [34].
Supporting Information
Figure S1 in File S1 Asthma-associated SNPs and
H3K4me1 (enhancer) enriched regions in the human
IKZF3 locus of different cell/tissue types. From top to
bottom, using the UCSC genome browser, are displayed: the gene
track (genes), all the SNPs not associated with asthma, the SNPs
associated with asthma (red are GWAS-identified SNPs, blue are
SNPs in linkage disequilibrium), H3K4me1 ChIP-seq track (green)
for different cell/tissue types (named on the left) underlined by the
corresponding peak-calling track (black boxes). For the blood
CD4+ T cells, peak calling tracks from seven samples/cell-types
are displayed. The red box shows an H3K4me1 peak that is
present only in CD4+ T cells.
(PDF)
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